Nervonic Acid from Malania oleifera Reverses Parkinson’s Disease by Regulating Oxidative Stress, Neuroinflammation, and Gut Microbiota
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 08.05.2026. Verfasst von Yuwen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra, accompanied by oxidative stress and neuroinflammation. While nervonic acid (NA) is recognized as an essential component of myelin sphingolipids, its specific therapeutic mechanisms in PD have not been thoroughly elucidated. In this study, we investigated the neuroprotective potential of NA derived from Malania oleifera and elucidated its underlying multimechanistic effect. We demonstrated that NA targets the core drivers of neuronal injury by restoring PTEN-induced kinase 1–Parkin-mediated mitophagy to alleviate mitochondrial dysfunction and oxidative stress. Concurrently, NA reprograms microglia from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype, thereby inhibiting cytokine secretion and resolving neuroinflammation. Beyond these central protective effects, metabolomics analysis revealed that NA serves as a direct biosynthetic precursor for long-chain ceramides, facilitating myelin regeneration. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced PD mice, these synergistic mechanisms collectively preserved dopaminergic neurons and improved motor function substantially. Furthermore, 16S ribosomal RNA amplicon sequencing revealed an associative remodeling of the gut microbiota, specifically enriching beneficial genera such as Akkermansia . Collectively, this study establishes NA as a potent multitarget therapeutic that concurrently regulates oxidative stress, neuroinflammation, and myelin regeneration to alleviate PD pathology.
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China.
- Jinhua Institute of Zhejiang University, Jinhua 321299, Zhejiang, PR China.
ORCID-Profile: Lihua Peng
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Peng, X., Xu, Y., Zhao, J., Chen, Y., Liu, X., & Peng, L. (2026). Nervonic Acid from Malania oleifera Reverses Parkinson’s Disease by Regulating Oxidative Stress, Neuroinflammation, and Gut Microbiota. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0349
Vancouver
Li Y, Peng X, Xu Y, Zhao J, Chen Y, Liu X, et al. Nervonic Acid from Malania oleifera Reverses Parkinson’s Disease by Regulating Oxidative Stress, Neuroinflammation, and Gut Microbiota. Biomaterials Research. 2026;30. doi:10.34133/bmr.0349
BibTeX
@article{Li2026,
author = {Li, Yuwen and Peng, Xiao and Xu, Yang and Zhao, Jingyu and Chen, Yong and Liu, Xuesong and Peng, Lihua},
title = {Nervonic Acid from Malania oleifera Reverses Parkinson’s Disease by Regulating Oxidative Stress, Neuroinflammation, and Gut Microbiota},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0349}
}
EUVIMED